Contributors Corner Eps 12-Digging Deeper: Why the Big Players Are Betting on Junior Miners"
Big-cap mining companies are facing a major problem: dwindling reserves and a lack of new discoveries. Instead of taking on early-stage risk themselves, they're increasingly turning to junior explorers to do the heavy lifting—making small caps the new hunting ground for future supply.
In this episode of Contributors Corner, we unpack this shift with Paul Sun, CEO of Eminent Gold (TSXV: EMNT), a junior explorer operating in Nevada that's already caught market attention with its high-potential targets and technical team stacked with major mining pedigrees.
Paul shares how this surge in strategic interest is reshaping the junior space, what big players are really looking for, and how companies like Eminent are positioning themselves to benefit. With capital tighter than ever, majors are becoming more selective, and the juniors with real assets and seasoned leadership are standing out.
🎙️ Listen in as we explore how this top-down investment trend is creating new momentum for juniors and why it might just mark the start of a major shift in mining's capital landscape.
🌍 Learn more about Eminent Gold at eminentgoldcorp.com
Check out our past issues of Contributors Corner where Michael Succurro from Spark Financial and Lyndsay Malchuk break open the topics that matter most for your portfolio and Bundeep Singh from Fineqia gives us all the 4-1-1 on crypto and blockchain
DISCLAIMER: These conversations are packed full of useful knowledge for your portfolio decisions, and remember these are the opinions of our own, with vested interests in particular assets and companies. Always be sure you speak with your Financial Advisor and know your own risk tolerance. For full disclaimer information, please click here
To stay up-to-date on all of your market news head to stockhouse.com
Join the discussion: Find out what everybody's saying check out the rest of Stockhouse's stock forums and message boards.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
40 minutes ago
- Cision Canada
AGEDB Technology Cancels Share Consolidation
VANCOUVER, BC, Aug. 11, 2025 /CNW/ - AGEDB Technology Ltd. (" AGEDB" or the " Company") (TSXV: AGET) announces that, further to the Company's news release dated June 10, 2025, the Board of Directors have determined not to proceed on the consolidation of the Company's common shares at this time. About AGEDB Technology Ltd. AGEDB Technology Ltd. (TSXV : AGET) is a leading provider of enterprise database solutions. The company specializes in advanced database technologies, including graph databases and data processing systems, offering robust solutions to clients worldwide. AGEDB Technology Ltd. On behalf of the board of directors, "Young Seung Ko" Director Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains statements that constitute "forward-looking statements." Such forward looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur. SOURCE AGEDB Technology Ltd.
Cision Canada
2 hours ago
- Cision Canada
Perimeter Announces Preliminary Unaudited Revenues for the 2025 Second Quarter; Reduces Operating Costs by ~30% as Company Focuses on Commercial Sales Pipeline and Growth Opportunities
– Webcasted Q2-2025 conference call scheduled for August 26 th at 5:00 PM EDT – TORONTO and DALLAS, Aug. 11, 2025 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced preliminary unaudited revenues for the second quarter ended June 30, 2025, senior management changes, and the creation of a Perimeter Industry Advisory Board ("IAB"). Preliminary Unaudited Second Quarter 2025 Revenues Unless otherwise indicated, all amounts in this press release are expressed in U.S. dollars. Perimeter anticipates total revenue for the second quarter of 2025 to be approximately $500,000, representing year-over-year growth of approximately 100%. Sequentially, the Company expects that greater than 35% procedure growth will result in over 50% recurring revenue growth in Q2-2025 compared to Q1-2025. This was primarily driven by stronger current Perimeter S-Series system utilization, with significantly more interoperative OTC imaging procedures performed by existing surgeon users, and at a higher price per procedure. For the six-month period ended June 30, 2025, total revenue is expected to be approximately $1.0 million, compared to $345,000 in the 6-month period ended June 30, 2024 and $846,000 for the full year ended December 31, 2024. Gross margin is expected to be approximately 69% for the second quarter and 61% for the six-month period ended June 30, 2025, respectively. "We are excited that the growing adoption, both in terms of new system placements and increased current device utilization, we saw during the first three months of the year continued through the second quarter," commented Adrian Mendes, Perimeter's Chief Executive Officer. "To put that into perspective, six-month 2025 revenue alone is estimated to surpass revenues for all of 2024. Now, as our sales pipeline continues to build, and with the Premarket Approval application for our next-generation Perimeter B-Series under review with the FDA, we anticipate a continuation of strong growth moving forward." Further, Perimeter advised that it expects initial savings from its cost control efforts will result in an approximate 30% reduction in total operating costs, starting in Q3-2025. These figures are preliminary and unaudited, and actual revenues may differ. Perimeter is providing this information due to planned investment community meetings to be held ahead of its Q2-2025 financial results release and conference call later this month. Leadership Changes Perimeter announced today the appointments of Abbey Goodman as Vice President, Sales, and Paolo DiPasquale as Vice President, Corporate Development, in a move designed to further position the Company for continued sales success and growth: Ms. Goodman brings over 20 years of medical device sales experience, most recently serving as Profound Medical's Global Chief Commercial Officer. Prior to joining Profound, she progressed through a variety of senior sales leadership roles with Hologic, Novadaq Technologies, Covidien (now Medtronic), and DePuy Mitek. Ms. Goodman earned a BS in Biological Engineering from Louisiana State University. Mr. DiPasquale brings a unique perspective as someone who has over 17 years of experience in the U.S. and Canadian capital markets across Equity Research, Institutional Equity, and Investment Banking at Canaccord Genuity and Stephens. Most recently, he served as Chief Strategy Officer of a gaming and marketing company, where he managed its successful capital raising strategy and go-public process on NASDAQ. Mr. DiPasquale is a graduate of Duquesne University with two majors: a BSc in Finance and a BSc in Investment Management. In addition, Perimeter announced that Tom Boon has recently retired as Perimeter's Chief Operating Officer. Mr. Boon will continue to help guide the Company's commercial strategy through his membership on Perimeter's newly formed IAB (please see below). "We are excited to welcome Abbey and Paolo to the Perimeter team. They bring deep expertise and leadership that will be critical as we advance our business," said Mr. Mendes. "At the same time, we want to thank Tom for his outstanding leadership and contributions to Perimeter. We look forward to continuing to work with him in his new capacity on our IAB." Creation of Perimeter Industry Advisory Board Perimeter also announces the creation of an IAB to support the Company's growth strategies across all products, channels and geographies. Chairing the IAB will be Diana Chan, Managing Director of BridgeGap Solutions Group. With over 20 years of experience in the medical device industry, Ms. Chan is a seasoned marketing leader dedicated to driving growth and innovation. She played a key role in MOLLI Surgical's journey, from building its brand presence and implementing growth strategies to its successful exit after three years of commercialization through its acquisition by Stryker Corporation. Currently, she provides advisory and mentorship in the medtech space through BridgeGap Solutions Group, a consultancy she founded to support organizations with limited resources in business and market development. Prior to MOLLI Surgical, she held executive positions at Medtronic, Bard, and Fresenius Medical Care. Ms. Chan received a BA in Administrative and Commercial Studies from Western University, and an MBA from the University of Notre Dame. The full mandate and initial composition of the IAB will be announced at a later date. Conference Call Perimeter will report its second quarter 2025 financial and operating results after market close on August 26, 2025. Following the announcement, the Company will host a conference call and live audio webcast at 5:00 pm Eastern Time to discuss the results and provide a corporate update. To participate in the call, please dial 1-800-717-1738 or 1-646-307-1865. The conference call will also be broadcast live online through a listen-only webcast, which will be posted on the Investors section of the Company's website and archived for approximately 90 days. About Perimeter Medical Imaging AI, Inc. Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSXV: PINK) (OTCQX: PYNKF) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that has recently been evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The company's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month. Perimeter B-Series OCT is limited by U.S. law to investigational use and not available for sale in the United States. Perimeter S-Series OCT has 510(k) clearance under a general indication and has not been evaluated by the U.S. FDA specifically for use in breast tissue, breast cancer, other types of cancer, margin evaluation, and reducing re-excision rates. The safety and effectiveness of these uses has not been established. For more information, please visit Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the Company's results for the three and six months June 30, 2025, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, information regarding management's views regarding the second quarter, the potential benefits of Perimeter S-Series OCT and Perimeter B-Series OCT and the expected benefits of Perimeter's updated version of its ImgAssist AI are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Management Discussion and Analysis and Annual Information Form for the year ended December 31, 2024, which are available on Perimeter's SEDAR+ profile at and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws. Financial Outlook This press release contains a financial outlook within the meaning of applicable Canadian securities laws. The financial outlook has been prepared by management of the Company to provide an outlook for the Company's forecasted revenue for the three and six months ended June 30, 2025 and may not be appropriate for any other purpose. The financial outlook has been prepared based on a number of assumptions including the assumptions discussed under the heading "Forward-Looking Statements" herein. The actual results of the Company's operations for any period will likely vary from the amounts set forth in these projections and such variations may be material. The Company and its management believe that the financial outlook has been prepared on a reasonable basis. However, because this information is highly subjective and subject to numerous risks, including the risks discussed under the heading "Forward-Looking Statements" herein, it should not be relied on as necessarily indicative of future results. Stephen Kilmer Investor Relations Direct: 647-872-4849 Email: [email protected] Adrian Mendes Chief Executive Officer Toll-free: 888-988-7465 (PINK) Email: [email protected]
The Market Online
6 hours ago
- The Market Online
The best-performing Canadian micro-cap stock since Aug. 2024
When we look back over the past year, Canadian-listed micro-caps have posted some superlative returns, but only one stock stands alone as the best-performing, delivering a 2,775 per cent return year-over-year as of August 11, and that's Goldgroup Mining (TSXV:GGA) The company operates two 100-per-cent-owned gold assets in Mexico with long-term growth potential CEO Ralph Shearing, founder of successful Mexican gold, silver, lead, zinc and copper producer Luca Mining (TSXV:LUCA), de-risks Golgroup's path forward thanks to his almost 40 years of junior mining executive experience When we look back over the past year, Canadian-listed micro-caps have posted some superlative returns, but only one stock stands alone as the best-performing, delivering a 2,775 per cent return year-over-year as of August 11, and that's Goldgroup Mining (TSXV:GGA). This content has been prepared as part of a partnership with Goldgroup Mining Inc., and is intended for informational purposes only. The assets Goldgroup operates two 100-per-cent-owned gold assets in Mexico with long-term growth potential. Here's a breakdown: The producing Cerro Prieto heap-leach gold mine in the state of Sonora delivers about 11,500 ounces per year. An ongoing optimization program seeks to increase this output to more than 30,000 ounces, while concurrent exploration vies to expand the resource. The past-producing Pinos underground gold project in the state of Zacatecas boasts a 2018 preliminary economic assessment (PEA) – based on an initial resource of 86,000 ounces of gold and 1.3 million ounces of silver measured and indicated – which management is in the process of updating to substantiate a return to production to exploit the property's extensive gold and silver vein systems. The run-up Goldgroup's leadership team, guided by CEO Ralph Shearing, a junior mining executive of almost 40 years, and the founder of successful Mexican gold, silver, lead, zinc and copper producer Luca Mining (TSXV:LUCA), began the company's recent run-up in shareholder value with the acquisition of the Pinos project in August 2024, granting it exposure to historic production grades averaging 30–50 grams per ton (g/t) of gold. The company followed this news up with metallurgical testing at Cerro Prieto in October demonstrating the potential for higher gold and silver recoveries versus historical results, significantly enhancing the operation's path to profitability. Management acted swiftly on this upside, instituting crushing and leaching improvements to increase production to 25,000 ounces per year. Positive news flow continued in March 2025, when Goldgroup secured a C$6.75 million investment from top junior mining supporter Eric Sprott, affording him 17.6 per cent ownership on a partially diluted basis, while enabling the company to advance mine improvements at Cerro Prieto, Pinos' PEA update and debt reduction, as well as top up general working capital. Sprott invested another C$3 million in May as part of a separate C$15 million private placement to expedite the company's growth initiatives. Goldgroup finalized its Pinos acquisition on July 3rd, adding 11.11 per cent to the stock through the following trading week to about the C$1.10 mark, where it has been range-bound to date, topping out at C$1.18 on July 25. The company's latest C$12 million financing, closed on August 5th, featured yet another show of conviction from Sprott, who added C$1.5 million to his position. The question of whether or not Goldgroup stock will continue to add to its multi-bagger run depends a handful of factors, including Cerro Prieto production and resource expansion, Pinos' ramp-up to a construction decision and eventual production, as well as resilience in the gold price, which has been range-bound near an all-time-high of more than US$3,500 per ounce since April. While the economy will fluctuate according to its own whims, making gold price predictions a coin toss over the long term, the likely lasting effects of US President Trump's tariff regime, including inflation and supply chain disruptions, point to lower earnings and highlight gold's enduring appeal, which has long proven its worth as a hedge and portfolio diversifier. Should the price per ounce hold, Goldgroup is in a favorable position to move its projects forward, thanks to C$26 million in cash and equivalents as of July 2025, a CEO well-versed in the Mexican mining industry to allocate it, and numerous high-potential targets to build value by increasing project quality as the company vies to improve margins and nudge its income statements towards cash generation. Join the discussion: Find out what everybody's saying about this best-performing Canadian micro-cap stock on the Goldgroup Mining Inc. Bullboard and check out the rest of Stockhouse's stock forums and message boards. *Returns data for Canadian-listed stocks up to C$300 million in market capitalization according to The Globe and Mail's stock screener as of August 11, 2025. Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.
